Chancery Asks If It's Right Venue For Biotech Stock Drop Suit

Attorneys sparring in Delaware's Chancery Court over a weeks-long, costly delay in Frequency Therapeutics Inc. stockholder share sales in 2021 while a top officer's transactions moved promptly will first have to...

Already a subscriber? Click here to view full article